PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880643
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1880643
Standard Pen Needles Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of standard pen needles Market
The global standard pen needles market is witnessing steady growth driven by the rising prevalence of diabetes, increasing adoption of insulin pens, and ongoing technological innovations in needle design. According to the latest market assessment, the market was valued at USD 1.56 billion in 2024, projected to grow to USD 1.65 billion in 2025, and is expected to reach USD 2.62 billion by 2032, reflecting a CAGR of 6.8% over the forecast period. North America dominated the market in 2024, holding a 38.46% share, supported by advanced healthcare infrastructure, widespread awareness, and strong adoption of home-based diabetes management solutions.
Standard pen needles are single-use medical devices used for subcutaneous delivery of insulin and other injectable medications via insulin pens. They are available in various gauges and lengths, designed to enhance precision, comfort, and convenience, particularly for self-administration. The market's growth is primarily fueled by the global surge in diabetes cases, rising preference for insulin pens over traditional syringes, and the adoption of ultra-fine and shorter needle designs that improve patient compliance, especially among needle-phobic users.
Market Drivers
The primary growth driver is the rising global prevalence of diabetes. Factors such as sedentary lifestyles, aging populations, increasing obesity rates, and poor dietary habits have contributed to a surge in diabetes diagnoses worldwide. According to the International Diabetes Federation, over 530 million adults were living with diabetes in 2023, with numbers expected to increase significantly in the coming decades. The widespread use of insulin therapy, particularly for Type 1 and advanced Type 2 diabetes, has amplified the demand for compatible pen needles.
The increasing adoption of insulin pens is another key driver. Insulin pens offer ease of use, portability, and accurate dosing, making them the preferred choice over traditional syringes. Educational campaigns and government initiatives aimed at improving diabetes awareness and access to insulin delivery devices further strengthen market growth. For instance, in August 2024, Breakthrough T1D launched the national campaign "Detect so you can decide," promoting early detection and insulin usage.
Market Restraints
The market faces certain constraints due to needle phobia, poor injection compliance, and lack of adherence to guidelines. Approximately 28% of diabetic patients worldwide experience anxiety or fear related to needle-based injections, potentially reducing adherence to prescribed insulin regimens. Reuse of pen needles, particularly in developing regions, further limits market expansion. In addition, inconsistent reimbursement policies and limited awareness in some regions hamper widespread adoption.
Market Opportunities
Expanding the market in middle-income countries offers significant opportunities. Regions in Asia, Latin America, and Africa are experiencing rapid increases in diabetes prevalence. Companies like Novo Nordisk are actively supplying insulin pens at reduced prices in countries like South Africa, promoting affordability and accessibility. Governments and NGOs focusing on non-communicable diseases present additional growth opportunities through local partnerships, product customization, and distribution networks.
Market Trends
Technological innovations are reshaping the market. Manufacturers are developing ultra-fine, thin-gauge needles with shorter lengths and advanced lubrication coatings to reduce pain and improve adherence. Safety-engineered mechanisms, including retractable needles and shielded designs, minimize needlestick injury risks. Integration with digital smart pens allows real-time insulin dose tracking, enhancing patient compliance and enabling remote disease management.
Segmentation Analysis
- By Drug Type: The insulin segment dominates due to long-term and widespread use, while GLP-1 therapies are projected to grow as new treatments for obesity and diabetes are approved.
- By Disease Indication: Diabetes leads due to the large patient base requiring chronic injectable therapies, whereas obesity shows promising growth as more patients adopt subcutaneous treatment regimens.
- By Needle Size: The 4 mm needle dominates for comfort and reduced intramuscular injection risk. 6 mm needles are growing for adults with higher BMI or obesity treatment.
- By Distribution Channel: Retail pharmacies account for the largest share, offering convenience and accessibility, while online pharmacies are expected to grow fastest, supported by e-commerce and telehealth expansion.
Regional Outlook
- North America dominated with USD 0.60 billion in 2024, benefiting from advanced healthcare infrastructure, home-based diabetes monitoring, and favorable reimbursement policies.
- Europe holds a significant share due to robust healthcare systems and high awareness of self-injection therapies.
- Asia Pacific is projected to witness the highest CAGR, fueled by increasing diabetes prevalence in China and India, growing health awareness, and improved healthcare access.
- Latin America and Middle East & Africa are growing steadily, driven by government initiatives, rising chronic disease awareness, and expanding healthcare infrastructure.
Competitive Landscape
The market is fragmented, with major players including Embecta Corp., BD, Cardinal Health, Terumo Corporation, and Owen Mumford. Companies focus on new product launches, strategic partnerships, and geographical expansion to maintain market share. Notable developments include Braun SE's 2025 collaboration with Orlando Health to develop innovative solutions improving patient access to insulin delivery devices.
In conclusion, the standard pen needles market is set to grow from USD 1.56 billion in 2024 to USD 2.62 billion by 2032, driven by rising diabetes prevalence, adoption of insulin pens, and technological advancements. With increased home-based care, patient-friendly needle designs, and expanding market access in emerging regions, the industry is poised for sustainable growth worldwide.
Segmentation By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Region
By Drug Type * Insulin
- GLP-1
- Growth Hormone
- Others
By Disease Indication * Diabetes
- Obesity
- Hormone Deficiency
- Others
By Needle Size * 4 mm
- 5 mm
- 6 mm
- 8 mm
- 12 mm
By Distribution Channel * Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
By Region * North America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country)
U.S.
Canada
- Europe (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
Germany
U.K.
France
Spain
Italy
Rest of Europe
- Asia Pacific (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
China
Japan
India
Australia
Rest of Asia Pacific
- Latin America (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
Brazil
Mexico
Rest of Latin America
- Middle East & Africa (By Drug Type, Disease Indication, Needle Size, Distribution Channel, and Country/Sub-region)
GCC
South Africa
Rest of the Middle East & Africa
Table of Content
1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
2. Executive Summary
3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
4. Key Insights
- 4.1. New Product Launches, By Key Players
- 4.2. Key Industry Developments (Mergers, Acquisitions, Partnerships, and Others)
- 4.3. Technological Advancements in Biopharmaceutical Processing
5. Global Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 5.1. Market Analysis, Insights and Forecast - By Drug Type
- 5.1.1. Insulin
- 5.1.2. GLP-1
- 5.1.3. Growth Hormone
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast - By Disease Indication
- 5.2.1. Diabetes
- 5.2.2. Obesity
- 5.2.3. Hormone Deficiency
- 5.2.4. Others
- 5.3. Market Analysis, Insights and Forecast - By Needle Size
- 5.3.1. 4 mm
- 5.3.2. 5 mm
- 5.3.3. 6 mm
- 5.3.4. 8 mm
- 5.3.5. 12 mm
- 5.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 5.4.1. Hospital Pharmacy
- 5.4.2. Retail Pharmacy
- 5.4.3. Online Pharmacy
- 5.5. Market Analysis, Insights and Forecast - By Region
- 5.5.1. North America
- 5.5.2. Europe
- 5.5.3. Asia Pacific
- 5.5.4. Latin America
- 5.5.5. Middle East & Africa
6. North America Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 6.1. Market Analysis, Insights and Forecast - By Drug Type
- 6.1.1. Insulin
- 6.1.2. GLP-1
- 6.1.3. Growth Hormone
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast - By Disease Indication
- 6.2.1. Diabetes
- 6.2.2. Obesity
- 6.2.3. Hormone Deficiency
- 6.2.4. Others
- 6.3. Market Analysis, Insights and Forecast - By Needle Size
- 6.3.1. 4 mm
- 6.3.2. 5 mm
- 6.3.3. 6 mm
- 6.3.4. 8 mm
- 6.3.5. 12 mm
- 6.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 6.4.1. Hospital Pharmacy
- 6.4.2. Retail Pharmacy
- 6.4.3. Online Pharmacy
- 6.5. Market Analysis, Insights and Forecast - By Country
- 6.5.1. U.S.
- 6.5.2. Canada
7. Europe Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 7.1. Market Analysis, Insights and Forecast - By Drug Type
- 7.1.1. Insulin
- 7.1.2. GLP-1
- 7.1.3. Growth Hormone
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast - By Disease Indication
- 7.2.1. Diabetes
- 7.2.2. Obesity
- 7.2.3. Hormone Deficiency
- 7.2.4. Others
- 7.3. Market Analysis, Insights and Forecast - By Needle Size
- 7.3.1. 4 mm
- 7.3.2. 5 mm
- 7.3.3. 6 mm
- 7.3.4. 8 mm
- 7.3.5. 12 mm
- 7.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 7.4.1. Hospital Pharmacy
- 7.4.2. Retail Pharmacy
- 7.4.3. Online Pharmacy
- 7.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 7.5.1. U.K.
- 7.5.2. Germany
- 7.5.3. France
- 7.5.4. Spain
- 7.5.5. Italy
- 7.5.6. Scandinavia
- 7.5.7. Rest of Europe
8. Asia pacific Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 8.1. Market Analysis, Insights and Forecast - By Drug Type
- 8.1.1. Insulin
- 8.1.2. GLP-1
- 8.1.3. Growth Hormone
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast - By Disease Indication
- 8.2.1. Diabetes
- 8.2.2. Obesity
- 8.2.3. Hormone Deficiency
- 8.2.4. Others
- 8.3. Market Analysis, Insights and Forecast - By Needle Size
- 8.3.1. 4 mm
- 8.3.2. 5 mm
- 8.3.3. 6 mm
- 8.3.4. 8 mm
- 8.3.5. 12 mm
- 8.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 8.4.1. Hospital Pharmacy
- 8.4.2. Retail Pharmacy
- 8.4.3. Online Pharmacy
- 8.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 8.5.1. Japan
- 8.5.2. China
- 8.5.3. India
- 8.5.4. Australia
- 8.5.5. Southeast Asia
- 8.5.6. Rest of Asia Pacific
9. Latin America Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 9.1. Market Analysis, Insights and Forecast - By Drug Type
- 9.1.1. Insulin
- 9.1.2. GLP-1
- 9.1.3. Growth Hormone
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast - By Disease Indication
- 9.2.1. Diabetes
- 9.2.2. Obesity
- 9.2.3. Hormone Deficiency
- 9.2.4. Others
- 9.3. Market Analysis, Insights and Forecast - By Needle Size
- 9.3.1. 4 mm
- 9.3.2. 5 mm
- 9.3.3. 6 mm
- 9.3.4. 8 mm
- 9.3.5. 12 mm
- 9.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 9.4.1. Hospital Pharmacy
- 9.4.2. Retail Pharmacy
- 9.4.3. Online Pharmacy
- 9.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 9.5.1. Brazil
- 9.5.2. Mexico
- 9.5.3. Rest of Latin America
10. Middle East & Africa Standard Pen Needles Market Analysis, Insights and Forecast, 2019-2032
- 10.1. Market Analysis, Insights and Forecast - By Drug Type
- 10.1.1. Insulin
- 10.1.2. GLP-1
- 10.1.3. Growth Hormone
- 10.1.4. Others
- 10.2. Market Analysis, Insights and Forecast - By Disease Indication
- 10.2.1. Diabetes
- 10.2.2. Obesity
- 10.2.3. Hormone Deficiency
- 10.2.4. Others
- 10.3. Market Analysis, Insights and Forecast - By Needle Size
- 10.3.1. 4 mm
- 10.3.2. 5 mm
- 10.3.3. 6 mm
- 10.3.4. 8 mm
- 10.3.5. 12 mm
- 10.4. Market Analysis, Insights and Forecast - By Distribution Channel
- 10.4.1. Hospital Pharmacy
- 10.4.2. Retail Pharmacy
- 10.4.3. Online Pharmacy
- 10.5. Market Analysis, Insights and Forecast - By Country/Sub-region
- 10.5.1. GCC
- 10.5.2. South Africa
- 10.5.3. Rest of Middle East & Africa
11. Competitive Analysis
- 11.1. Global Market Share Analysis (2024)
- 11.2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
- 11.2.1. Embecta Corp.
- 11.2.2. Cardinal Health
- 11.2.3. MTD Medical Technology and Devices
- 11.2.4. UltiMed, Inc.
- 11.2.5. Allison Medical, Inc.
- 11.2.6. Owen Mumford
- 11.2.7. Medline Industries, LP
- 11.2.8. B. Braun SE
- 11.2.9. Neon Diagnostics Limited
- 11.2.10. Other Prominent Players
List of Tables
- Table 1: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 2: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 3: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 4: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 5: Global Standard Pen Needles Market Revenue (USD billion) Forecast, by Region, 2019-2032
- Table 6: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 7: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 8: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 9: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 10: North America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country, 2019-2032
- Table 11: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 12: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 13: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 14: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 15: Europe Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032
- Table 16: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 17: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 18: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 19: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 20: Asia Pacific Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032
- Table 21: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 22: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 23: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 24: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 25: Latin America Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032
- Table 26: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Drug Type, 2019-2032
- Table 27: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Disease Indication, 2019-2032
- Table 28: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Needle Size, 2019-2032
- Table 29: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Distribution Channel, 2019-2032
- Table 30: Middle East & Africa Standard Pen Needles Market Revenue (USD billion) Forecast, by Country/Sub-Region, 2019-2032
List of Figures
- Figure 1: Global Standard Pen Needles Market Revenue Breakdown (USD billion, %) by Region, 2024 & 2032
- Figure 2: Global Standard Pen Needles Market Value Share (%), by Drug Type, 2024 & 2032
- Figure 3: Global Standard Pen Needles Market Value Share (%), by Disease Indication, 2024 & 2032
- Figure 4: Global Standard Pen Needles Market Value Share (%), by Needle Size, 2024 & 2032
- Figure 5: Global Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024 & 2032
- Figure 6: Global Standard Pen Needles Market Value (USD billion), by Region, 2024 & 2032
- Figure 7: North America Standard Pen Needles Market Value (USD billion), by Drug Type, 2024 & 2032
- Figure 8: North America Standard Pen Needles Market Value Share (%), by Drug Type, 2024
- Figure 9: North America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2024 & 2032
- Figure 10: North America Standard Pen Needles Market Value Share (%), by Disease Indication, 2024
- Figure 11: North America Standard Pen Needles Market Value (USD billion), by Needle Size, 2024 & 2032
- Figure 12: North America Standard Pen Needles Market Value Share (%), by Needle Size, 2024
- Figure 13: North America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 14: North America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024
- Figure 15: North America Standard Pen Needles Market Value (USD billion), By Country, 2024 & 2032
- Figure 16: North America Standard Pen Needles Market Value Share (%), By Country, 2024
- Figure 17: Europe Standard Pen Needles Market Value (USD billion), by Drug Type, 2024 & 2032
- Figure 18: Europe Standard Pen Needles Market Value Share (%), by Drug Type, 2024
- Figure 19: Europe Standard Pen Needles Market Value (USD billion), by Disease Indication, 2024 & 2032
- Figure 20: Europe Standard Pen Needles Market Value Share (%), by Disease Indication, 2024
- Figure 21: Europe Standard Pen Needles Market Value (USD billion), by Needle Size, 2024 & 2032
- Figure 22: Europe Standard Pen Needles Market Value Share (%), by Needle Size, 2024
- Figure 23: Europe Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 24: Europe Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024
- Figure 25: Europe Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2024 & 2032
- Figure 26: Europe Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2024
- Figure 27: Asia Pacific Standard Pen Needles Market Value (USD billion), by Drug Type, 2024 & 2032
- Figure 28: Asia Pacific Standard Pen Needles Market Value Share (%), by Drug Type, 2024
- Figure 29: Asia Pacific Standard Pen Needles Market Value (USD billion), by Disease Indication, 2024 & 2032
- Figure 30: Asia Pacific Standard Pen Needles Market Value Share (%), by Disease Indication, 2024
- Figure 31: Asia Pacific Standard Pen Needles Market Value (USD billion), by Needle Size, 2024 & 2032
- Figure 32: Asia Pacific Standard Pen Needles Market Value Share (%), by Needle Size, 2024
- Figure 33: Asia Pacific Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 34: Asia Pacific Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024
- Figure 35: Asia Pacific Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2024 & 2032
- Figure 36: Asia Pacific Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2024
- Figure 37: Latin America Standard Pen Needles Market Value (USD billion), by Drug Type, 2024 & 2032
- Figure 38: Latin America Standard Pen Needles Market Value Share (%), by Drug Type, 2024
- Figure 39: Latin America Standard Pen Needles Market Value (USD billion), by Disease Indication, 2024 & 2032
- Figure 40: Latin America Standard Pen Needles Market Value Share (%), by Disease Indication, 2024
- Figure 41: Latin America Standard Pen Needles Market Value (USD billion), by Needle Size, 2024 & 2032
- Figure 42: Latin America Standard Pen Needles Market Value Share (%), by Needle Size, 2024
- Figure 43: Latin America Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 44: Latin America Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024
- Figure 45: Latin America Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2024 & 2032
- Figure 46: Latin America Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2024
- Figure 47: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Drug Type, 2024 & 2032
- Figure 48: Middle East & Africa Standard Pen Needles Market Value Share (%), by Drug Type, 2024
- Figure 49: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Disease Indication, 2024 & 2032
- Figure 50: Middle East & Africa Standard Pen Needles Market Value Share (%), by Disease Indication, 2024
- Figure 51: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Needle Size, 2024 & 2032
- Figure 52: Middle East & Africa Standard Pen Needles Market Value Share (%), by Needle Size, 2024
- Figure 53: Middle East & Africa Standard Pen Needles Market Value (USD billion), by Distribution Channel, 2024 & 2032
- Figure 54: Middle East & Africa Standard Pen Needles Market Value Share (%), by Distribution Channel, 2024
- Figure 55: Middle East & Africa Standard Pen Needles Market Value (USD billion), By Country/Sub-region, 2024 & 2032
- Figure 56: Middle East & Africa Standard Pen Needles Market Value Share (%), By Country/Sub-region, 2024
- Figure 57: Global Standard Pen Needles Market Share (%), 2024
